Results 11 to 20 of about 502,516 (332)

IgA nephropathy

open access: yesCleveland Clinic Journal of Medicine, 2023
Immunoglobulin A nephropathy (IgAN) is the most common glomerulonephritis in the world. The etiology is unknown but a dysregulated T-cell immune response to viral, bacterial, and food antigens activating mucosal plasma cells to produce polymeric IgA has been proposed. No serological test exists to diagnosis IgAN.
Jonathan J, Taliercio, Ali, Mehdi
openaire   +5 more sources

IgA NEPHROPATHY [PDF]

open access: yesAnnual Review of Medicine, 1987
IgA nephropathy is a syndrome and probably the most important glomerular disease in terms of incidence and mortality. This review documents the clinical and pathological features and concentrates on the evolving thoughts regarding pathogenesis and treatment.
A R, Clarkson   +4 more
openaire   +4 more sources

IgA nephropathy [PDF]

open access: yesNature Reviews Disease Primers, 2016
Globally, IgA nephropathy (IgAN) is the most common primary glomerulonephritis that can progress to renal failure. The exact pathogenesis of IgAN is not well defined, but current biochemical and genetic data implicate overproduction of aberrantly glycosylated IgA1.
Schena, FP   +6 more
openaire   +6 more sources

IgA Glycosylation in IgA Nephropathy [PDF]

open access: yes, 1998
IgA nephropathy (IgAN) is the commonest form of glomerulonephritis in developed countries where renal biopsy is widely practiced1. IgAN is defined by the deposition of IgA in the glomerular mesangium. Most typically, patients present with episodes of visible haematuria, which often concide with respiratory or gastrointestinal infection.
A, Allen, J, Feehally
openaire   +2 more sources

From contrastive rhetoric to intercultural rhetoric: Why intercultural rhetoric needs to reframe the concept of culture [PDF]

open access: yes, 2013
Udostępnienie publikacji Wydawnictwa Uniwersytetu Łódzkiego finansowane w ramach projektu „Doskonałość naukowa kluczem do doskonałości kształcenia”. Projekt realizowany jest ze środków Europejskiego Funduszu Społecznego w ramach Programu Operacyjnego ...
Lehman, Iga
core   +1 more source

IgA subclass and IgA deficiency

open access: yesJapanese Journal of Clinical Immunology, 2009
There are two subclasses of IgA, IgA1 and IgA2, and its heavy chains are encoded by two different genes, alpha1 and alpha2 genes. These two subclasses play important roles in the first line of defense, and the amount ratio of these molecules in secretions varies.
Hideo, Kaneko   +2 more
openaire   +3 more sources

Polyclonal Antibody Therapies for Clostridium difficile Infection

open access: yesAntibodies, 2014
Clostridium difficile infection has emerged as a growing worldwide health problem. The colitis of Clostridium difficile infection results from the synergistic action of C. difficile secreted toxins A and B upon the colon mucosa.
Michael R. Simon   +2 more
doaj   +1 more source

Stressful life events are associated with low secretion rates of immunoglobulin A in saliva in the middle aged and elderly [PDF]

open access: yes, 2006
Whether chronic stress experience is related to down-regulation of secretory immunoglobulin A (S-IgA) was tested in two substantial cohorts, one middle-aged (N = 640) and one elderly (N = 582), comprising similar numbers of men (N = 556) and women (N ...
Phillips, A.C.   +13 more
core   +1 more source

The mucosal adjuvant cholera toxin B instructs non-mucosal dendritic cells to promote IgA production via retinoic acid and TGF-β [PDF]

open access: yes, 2013
It is currently unknown how mucosal adjuvants cause induction of secretory immunoglobulin A (IgA), and how T cell-dependent (TD) or -independent (TI) pathways might be involved.
Boon, Louis   +13 more
core   +17 more sources

Simon, M.R., et al. Polyclonal Antibody Therapies for Clostridium difficile Infection. Antibodies 2014, 3, 272–288.

open access: yesAntibodies, 2015
The authors wish to add the following to the acknowledgments of [1]: [...]
Michael R. Simon   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy